Clinical Trial Update: Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial of ZN-A-1041 enteric capsules in HER2-positive advanced solid tumors has completed. The study enrolled patients with HER2-positive breast cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ZN-A-1041 Enteric Capsules (ZN-A-1041)

Snippet

Sponsor: Suzhou Zanrong Pharma Limited | Conditions: Advanced Solid Tumors, HER2-positive Breast Cancer | Phase 1 | Status: COMPLETED